Category Archives: Europe

Primary Care Diabetes Prescriptions Cost UK Over £2 Million a Day

Prescriptions to manage diabetes in primary care in the UK cost the NHS an average of £2.2 million ($3.7 m) every day in 2013-14, according to a report from the Health and Social Care Information Centre (HSCIC). The report, Prescribing for Diabetes, also shows the Net Ingredient Cost (NIC)  for managing diabetes was £803.1 million ($1,347 m) in 2013–14. […]
Also posted in Global, healthcare | Tagged , | Leave a comment

Pharma & Biotech Most Active Sector in UK M&As

The pharma, medical and biotech (PMB) sector, driven by the Novartis’s £8.6bn acquisition of GlaxoSmithKline’s oncology division, was the most active industry in UK M&A in H1 2014, with a 26.9% market share (£10.1bn), according to Mergermarket’s latest deal round-up. However M&A activity targeting the United Kingdom — standing at £37.5bn in H1 2014 — represented […]
Also posted in Deals | Tagged , , , , | Leave a comment

Europe Leads Generic-Drugs Assessment Project

The European Union’s  decentralized procedure is to be used by international regulatory agencies as a model for facilitating generic-drug application assessments, as part of the International Generic Drug Regulations Pilot (IGDRP) project. At the request of a generic-drug company, the EU will share assessment reports in real time with collaborating international regulatory agencies. According to […]
Also posted in Global | Tagged , , | Leave a comment

EMA Invites Comments on Good Biomarker Practice

The European Medicines Agency (EMA) has released a consultation on good genomics biomarker practices. The outcome of the consultation will inform a guideline, which will set criteria to underpin the generation of robust clinical genomic datasets throughout a medicine’s lifecycle,  the choice of genomic techniques and biomarkers, the impact on the relevant study design, and the […]
Also posted in Biotech, Global, Regulatory | Tagged , , | Leave a comment

EMA Invites Comments on Guidance for Flu Vaccines

The European Medicines Agency (EMA) has released the second module of a new overarching guideline on influenza vaccines for a six-month public consultation. The guidance covers the non-clinical and clinical requirements for the development of new influenza vaccines and aims to facilitate the prompt assessment of new vaccines. It follows the publication in April of […]
Also posted in Global, Regulatory | Tagged , | Leave a comment
  • Categories

  • Meta